383 related articles for article (PubMed ID: 19783956)
1. Nasal delivery of high molecular weight drugs.
Ozsoy Y; Gungor S; Cevher E
Molecules; 2009 Sep; 14(9):3754-79. PubMed ID: 19783956
[TBL] [Abstract][Full Text] [Related]
2. Nasal route and drug delivery systems.
Türker S; Onur E; Ozer Y
Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
4. Nasal route for vaccine and drug delivery: Features and current opportunities.
Lobaina Mato Y
Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
[TBL] [Abstract][Full Text] [Related]
5. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
6. Permeability issues in nasal drug delivery.
Arora P; Sharma S; Garg S
Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
[TBL] [Abstract][Full Text] [Related]
7. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
8. The nasal delivery of systemic drugs.
Jones NS; Quraishi S; Mason JD
Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the delivery of antidiabetic drugs via intranasal route.
Dholakia J; Prabhakar B; Shende P
Int J Pharm; 2021 Oct; 608():121068. PubMed ID: 34481011
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and solutions for nasal drug delivery - a narrative review.
Ulusoy S; Bayar Muluk N; Karpischenko S; Passali GC; Negm H; Passali D; Milkov M; Kopacheva-Barsova G; Konstantinidis I; Dilber M; Cingi C
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(2 Suppl):72-81. PubMed ID: 36524914
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
Singh RM; Kumar A; Pathak K
Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
[TBL] [Abstract][Full Text] [Related]
14. Nasal route: an alternative approach for antiemetic drug delivery.
Ozsoy Y; Güngör S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
[TBL] [Abstract][Full Text] [Related]
15. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
[TBL] [Abstract][Full Text] [Related]
16. [Intranasal delivery of systemic drugs: a new route for opioid drugs].
Devillier P; Grassin-Delyle S; Naline E; Buenestado A; Blouquit-Laye S; Advenier C
Therapie; 2010; 65(5):475-81. PubMed ID: 21144483
[TBL] [Abstract][Full Text] [Related]
17. Strategies to facilitate or block nose-to-brain drug delivery.
Martins PP; Smyth HDC; Cui Z
Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
[TBL] [Abstract][Full Text] [Related]
18. [Development of Prediction System for Drug Absorption after Intranasal Administration Incorporating Physiologic Functions of Nose -Estimation of in Vivo Drug Permeation through Nasal Mucosa Using in Vitro Membrane Permeability].
Inoue D
Yakugaku Zasshi; 2021; 141(11):1235-1240. PubMed ID: 34719543
[TBL] [Abstract][Full Text] [Related]
19. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
Oliveira P; Fortuna A; Alves G; Falcao A
Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
[TBL] [Abstract][Full Text] [Related]
20. [Site-specific drug delivery systems. III. Nasal drug delivery].
Szente V; Zelkó R
Acta Pharm Hung; 2008; 78(2):87-90. PubMed ID: 18807389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]